PROCEPT BioRobotics (PRCT) Accounts Payables (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Accounts Payables for 7 consecutive years, with $15.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accounts Payables rose 27.89% year-over-year to $15.1 million in Q2 2026; TTM through Jun 2026 was $15.1 million, a 27.89% increase from a year earlier, with the FY2025 full-year figure at $17.3 million, up 72.3% from the prior year.
• Accounts Payables was $15.1 million for Q2 2026 at PROCEPT BioRobotics, down from $18.9 million in the prior quarter.
• Over five years, Accounts Payables peaked at $18.9 million in Q1 2026 and troughed at $2.6 million in Q1 2022.
• A 5-year average of $11.3 million and a median of $10.7 million in 2023 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables surged 362.84% in 2022 and slipped 26.31% in 2025, its largest moves.
• Over 5 years, Accounts Payables stood at $9.4 million in 2022, then jumped by 43.74% to $13.5 million in 2023, then fell by 25.68% to $10.0 million in 2024, then jumped by 72.3% to $17.3 million in 2025, then declined by 12.82% to $15.1 million in 2026.
• The last three Accounts Payables figures came in at $15.1 million (Q2 2026), $18.9 million (Q1 2026), and $17.3 million (Q4 2025), per Business Quant data.